396
Participants
Start Date
October 26, 2016
Primary Completion Date
May 28, 2019
Study Completion Date
June 25, 2019
Pimavanserin
Pimavanserin 34 mg, 20 mg, or 10 mg , taken as two tablets once daily by mouth
Placebo
Placebo, taken as two tablets, once daily by mouth
Budapest
Budapest
Sofia
Sofia
Sofia
Sofia
Sofia
Vratsa
Plovdiv
Debrecen
Pazardzhik
Veliko Tarnovo
Tserova Koria
Veliko Tarnovo
Kalocsa
Pécs
Targovishte
Burgas
Varna
Belgrade
Jamaica
Cedarhurst
Rochester
Smila
Vinnytsia
Catonsville
Charlotte
Charleston
Atlanta
Atlanta
Miami
Lauderhill
Boca Raton
Poltava
Kaunas
Dayton
Ann Arbor
Kaunas
Dnipro
Kaunas
Hoffman Estates
Chicago
Chicago
Kharkiv
Odesa
Oleksandrivka
Lake Charles
Little Rock
Rogers
Kherson
Richardson
Salt Lake City
Phoenix
Las Vegas
Culver City
Torrance
Cerritos
Bellflower
Long Beach
Lemon Grove
San Diego
San Diego
Santa Ana
Šilutė
Moscow
Yaroslavl
Arkhangelsk
Roshchino
Saint Petersburg
Saint Petersburg
Saint Petersburg
Saint Petersburg
Saint Petersburg
Smolensk
Stavropol
Tonnel’nyy
Voronezh
Plekhanovo
Samara
Berlin
Chatham
Montreal
Toronto
Hradec Králové
Pilsen
Prague
Prague
Prague
Říčany
Vilnius
Bialystok
Bydgoszcz
Lublin
Lublin
Pruszcz Gdański
Belgrade
Kovin
Kragujevac
Niš
Hlevakha
Kyiv
Smila
Kyiv
Kyiv
Kyiv
Lead Sponsor
ACADIA Pharmaceuticals Inc.
INDUSTRY